Skip to main content

Table 4 Baseline data and 90th day of liver function levels, blood lipid profile and myopathy

From: The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy

 

Variable

Atorvastatin n = 42

Mean ± SD

Rivaroxaban n = 44

Mean ± SD

p

Pre-treatment

SGOT(mg/dL)

35,26 ± 21,44

36,98 ± 25,60

0,829†

SGPT (mg/dL)

29,93 ± 40,32

28,55 ± 30,04

0,772†

Total Bilirubin (mg/dL)

0,78 ± 0,87

0,69 ± 0,65

0,872†

Triglycerides(mg/dL)

158,74 ± 112,07

163,09 ± 78,66

0,265†

Total cholesterol (mg/dL)

176,17 ± 57,70

181,09 ± 72,87

0,890†

LDL cholesterol (mg/dL)

132,45 ± 42,08

131,66 ± 68,92

0,455†

HDL cholesterol (mg/dL)

36,20 ± 10,95

36,91 ± 17,48

0,424†

90th day

Signs of myopathy

0

0

-

SGOT(mg/dL)

50,69 ± 53,58

44,43 ± 38,90

0,565†

SGPT (mg/dL)

45,52 ± 62,97

29,09 ± 24,10

0,156†

Total Bilirubin (mg/dL)

0,80 ± 0,73

0,94 ± 1,69

0,245†

Triglycerides (mg/dL)

148,45 ± 92,92

175,93 ± 96,69

0,095†

Total cholesterol (mg/dL)

149,76 ± 52,61

187,89 ± 50,38

0,000†

LDL cholesterol (mg/dL)

91,48 ± 39,57

132,07 ± 49,25

0,000‡

HDL cholesterol (mg/dL)

34,60 ± 14,43

40,68 ± 30,97

0,385†

  1. †Mann–Whitney U Test
  2. ‡Independent T Test